Primary sclerosing cholangitis is changing clinical spectrum and old biomarkers disclose an innovative role: the case of alkaline phosphatase
Dig Liver Dis
.
2011 Apr;43(4):268-9.
doi: 10.1016/j.dld.2011.02.006.
Epub 2011 Feb 22.
Author
Pietro Invernizzi
1
Affiliation
1
Center for Autoimmune Liver Diseases, Division of Internal Medicine, IRCCS Istituto Clinico Humanitas, Rozzano, Italy. pietro.invernizzi@humanitas.it
PMID:
21345755
DOI:
10.1016/j.dld.2011.02.006
No abstract available
Publication types
Comment
MeSH terms
Alkaline Phosphatase / blood*
Biomarkers / blood*
Cholangitis, Sclerosing / enzymology
Cholangitis, Sclerosing / mortality
Humans
Prognosis
Survival Rate
Substances
Biomarkers
Alkaline Phosphatase